Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan Richards

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Med (New York, N.Y.)|December 9, 2020
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19Philip C Robinson, David F L Liew, Jean W Liew, et al.
British Journal of Clinical Pharmacology|October 30, 2023
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2Helen E Higham, Lauren Morgan, Cushla Cooper, et al.
Trials|August 19, 2020
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trialTimothy S C Hinks, Vicki S Barber, Joanna Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|June 30, 2018
Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE StudyAdam M Deane, Francois Lamontagne, George E Dukes, et al.
BMC Gastroenterology|July 20, 2016
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.
BMJ Open|November 12, 2021
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adultsTonny Veenith, Benjamin A Fisher, Daniel Slade, et al.
Lancet (London, England)|February 12, 2017
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a studyVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.
BMJ Open|September 28, 2023
Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritisAlexander Ooms, Hussein Al-Mossawi, Louise Bennett, et al.
BMJ Open|July 10, 2026
Clinical and cost-effectiveness of oral versus intramuscular glucocorticoids in rheumatoid arthritis: protocol for a multicentre randomised controlled trial with economic evaluation and qualitative sub-study (LEADER trial)Jonathan Alistair Cook, Nicky Wilson, Kate Wilkins, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Med (New York, N.Y.)|December 9, 2020
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19Philip C Robinson, David F L Liew, Jean W Liew, et al.
British Journal of Clinical Pharmacology|October 30, 2023
Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS-CoV-2Helen E Higham, Lauren Morgan, Cushla Cooper, et al.
Trials|August 19, 2020
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trialTimothy S C Hinks, Vicki S Barber, Joanna Black, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2022
COVID-19 therapeutics: Challenges and directions for the futurePhilip C Robinson, David F L Liew, Helen L Tanner, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|June 30, 2018
Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE StudyAdam M Deane, Francois Lamontagne, George E Dukes, et al.
BMC Gastroenterology|July 20, 2016
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.
BMJ Open|November 12, 2021
CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adultsTonny Veenith, Benjamin A Fisher, Daniel Slade, et al.
Lancet (London, England)|February 12, 2017
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a studyVinod S Hegade, Stuart F W Kendrick, Robert L Dobbins, et al.
BMJ Open|September 28, 2023
Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritisAlexander Ooms, Hussein Al-Mossawi, Louise Bennett, et al.
BMJ Open|July 10, 2026
Clinical and cost-effectiveness of oral versus intramuscular glucocorticoids in rheumatoid arthritis: protocol for a multicentre randomised controlled trial with economic evaluation and qualitative sub-study (LEADER trial)Jonathan Alistair Cook, Nicky Wilson, Kate Wilkins, et al.
Pageof 4